Search Results - "Braish J"

Longitudinal Whole-Exome Sequencing Identifies Clonal Hematopoiesis and Genomic Heterogeneity as a Predictor of Treatment Outcome in Patients with Newly Diagnosed, Elderly Chronic Lymphocytic Leukemia.

Authors: Jang, Ho Cheol Song, Ga-Young Jeong, Hyeonjin et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 6, p2610. 14p.

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes.

Authors: Bazinet A Bataller A Chien K et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Mar 27; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 27.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

NOTCH1 and SF3B1 mutations in chronic lymphocytic leukemia with their clinical associations.

Authors: Ahmed, Vanya Rashid Rahman, Fryad Majeed

Source: Leukemia & Lymphoma. Apr2026, Vol. 67 Issue 5, p1047-1054. 8p.

An overview of prognostic markers in patients with CLL.

Authors: Braish J Cerchione C Ferrajoli A

Source: Frontiers in oncology [Front Oncol] 2024 May 16; Vol. 14, pp. 1371057. Date of Electronic Publication: 2024 May 16 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Nanomechanical and Thermodynamic Alterations of Red Blood Cells in Chronic Lymphocytic Leukemia: Implications for Disease and Treatment Monitoring.

Authors: Strijkova, Velichka Katrova, Vesela Ivanova, Miroslava et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 1, p353. 21p.

Association of Galectin-9 Soluble Immune Checkpoint with Clinical Prognostic Markers in Patients with Chronic Lymphocytic Leukemia.

Authors: Ntsethe, Aviwe Dludla, Phiwayinkosi Vusi Nkambule, Bongani Brian

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 1, p98. 11p.

Diagnosis, prognostic prediction of the accelerated phase of chronic lymphocytic leukaemia: a narrative review.

Source: Contemporary Oncology / Współczesna Onkologia. 2026, Vol. 30 Issue 1, p1-10. 10p.

Evaluation of the relevance of serum level of interleukin-8 in chronic lymphocytic leukemia.

Authors: Sabir, Shahla'a Fadhil Al-Lateef, Huda Ibraheem Abd Hasan, Wurood Alaa et al.

Source: Iraqi Journal of Hematology. Jan-Jun2026, Vol. 15 Issue 1, p72-77. 6p.

From Sample to Sequencing: The Importance of Pre-Analytical Sample Treatment in NGS Analysis of Patients with Chronic Lymphocytic Leukemia.

Authors: Suver Stević, Mirjana Holik, Hrvoje Periša, Vlatka et al.

Source: Cancers. Nov2025, Vol. 17 Issue 22, p3668. 11p.

Investigating the prognostic value of non-coding RNAs in chronic lymphocytic leukemia: insights from a systematic review and meta-analysis.

Authors: Aghayan, Amir Hossein Arab, Ali Haddadi, Shadi et al.

Source: BMC Cancer. 11/10/2025, Vol. 25 Issue 1, p1-15. 15p.

The Evolving Landscape of microRNAs in Cholangiocarcinoma and Pancreatic Cancer.

Authors: Schneider, Andrada Ozana Birsan, Sabrina Anderco, Paula et al.

Source: Diagnostics (2075-4418). Sep2025, Vol. 15 Issue 18, p2285. 14p.

MLR Corresponds to the Functional Status of Monocytes in Chronic Lymphocytic Leukemia.

Authors: Grzegorzewska, Wioleta Zarobkiewicz, Michał Jastrzębska-Pawłowska, Katarzyna et al.

Source: International Journal of Inflammation. 8/8/2025, Vol. 2025, p1-20. 20p.

Multi-Omics Approaches to Understanding Therapy Resistance in Acute Lymphoblastic Leukemia.

Authors: Wu, Xiuyun Zhang, Jingxin

Source: Lymphatics. Mar2026, Vol. 4 Issue 1, p8. 15p.

Skeletal Involvement in Systemic Mastocytosis: Pathophysiology, Clinical Management, Standards of Care, and Novel Therapeutic Strategies.

Authors: Fazio, Manlio Bottaro, Adele Nasso, Maria Elisa et al.

Source: Cells (2073-4409). Feb2026, Vol. 15 Issue 3, p307. 33p.

High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia.

Authors: Tosic, Natasa Tomic Vujovic, Kristina Vukovic, Vojin et al.

Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 3, p1153. 19p.

Beta-2-Microglobulin Maintains Overall Survival Prediction in Binet A Stage Chronic Lymphocytic Leukemia Patients with Compromised Kidney Function in Both Treatment Eras of Chemoimmunotherapy and Targeted Agents.

Authors: Bohn, Jan-Paul Stolzlechner, Valentina Göbel, Georg et al.

Source: Cancers. Nov2024, Vol. 16 Issue 22, p3744. 10p.

Familial Mediterranean Fever Complicated By Massive Cardiac Tamponade.

Authors: Melo L Patail H Gautam G et al.

Source: Cureus [Cureus] 2023 Dec 07; Vol. 15 (12), pp. e50137. Date of Electronic Publication: 2023 Dec 07 (Print Publication: 2023).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE

Recent Advances in the Molecular Biology of Chronic Lymphocytic Leukemia: How to Define Prognosis and Guide Treatment.

Authors: Arcari, Annalisa Morello, Lucia Borotti, Elena et al.

Source: Cancers. Oct2024, Vol. 16 Issue 20, p3483. 23p.

Brigimadlin (BI-907828) and napabucasin (BBI608) cooperatively trigger apoptosis in chronic lymphocytic leukemia cells by simultaneous iİnhibition of MDM2 and STAT3.

Authors: Aptullahoglu E; Faculty of Science, Department of Molecular Biology and Genetics, Bilecik Şeyh Edebali University, Bilecik, 11100, Türkiye, Turkey. erhan.aptullahoglu@bilecik.edu.tr.; Biotechnology Application and Research Centre, Bilecik Şeyh Edebali University, Bilecik, 11100, Türkiye, Turkey. erhan.aptullahoglu@bilecik.edu.tr.

Source: Molecular biology reports [Mol Biol Rep] 2025 Jul 17; Vol. 52 (1), pp. 731. Date of Electronic Publication: 2025 Jul 17.

Publication Type: Journal Article

Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE

Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia.

Authors: Azevedo RS Braish J Gener-Ricos G et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Jan; Vol. 67 (1), pp. 220-224. Date of Electronic Publication: 2025 Oct 31.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process